Riskpilot← Back to searchSign inGet full accessCAERUS CAPITAL AS
ASActiveOrg 984276141Gabels Gate 43A, 0262 OsloManufacture of pharmaceutical preparations · NACE 2120Est. 20020 employees
Revenue 2024
NOK 1,6M
+28% vs 2023
EBITDA margin
98.0%
+28% vs 2023
Equity ratio
83.5%
Financial strength
Net profit 2024
NOK 2,6M
-4% vs 2023
| Revenue | NOK 1,6M | +28% |
| EBITDA | NOK 1,6M | +28% |
| Net profit | NOK 2,6M | -4% |
| Total assets | NOK 9,7M | +8% |
| Equity | NOK 8,1M | +47% |
| Employees | 0 | — |
Legal name
CAERUS CAPITAL AS
Org number
984276141
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
9. mars 2002
Share capital
NOK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Produktutvikling i farmasøytisk industri, konsulentvirksomhet, investeringsvirksomhet samt deltakelse i andre foretak.
Address
Gabels Gate 43A, 0262 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 105 | 0 | 350 | 667 | 583 | 0 | 0 | 109 | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 1 238 | 1 590 |
| Staff expenses | −0 | −0 | −0 | −0 | −4 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −1 058 | −1 233 | −423 | −1 123 | 46 | −124 | −35 | 59 | 32 | −59 | −33 | −35 | −20 | −22 | −21 | 1 216 | 1 559 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −100 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −1 058 | −1 233 | −423 | −1 123 | −54 | −124 | −35 | 59 | 32 | −59 | −33 | −35 | −20 | −22 | −21 | 1 216 | 1 559 |
| Net financials | 0 | −2 | 4 | 0 | −91 | 2 | 3 | 0 | 3 | 318 | 584 | −1 414 | 246 | −1 089 | 3 063 | −525 | 1 507 | 1 042 |
| Profit before tax | 0 | −1 060 | −1 229 | −423 | −1 214 | −52 | −121 | −35 | 62 | 350 | 525 | −1 446 | 211 | −1 109 | 3 041 | −546 | 2 722 | 2 601 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −1 060 | −1 229 | −423 | −1 214 | −52 | −121 | −35 | 62 | 350 | 525 | −1 446 | 211 | −1 109 | 3 041 | −546 | 2 722 | 2 601 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 297 | 362 | 486 | 2 122 | 1 882 | 194 | 101 | 557 | 3 717 | 5 688 | 3 442 | 3 528 | 3 696 | 6 486 | 6 246 | 8 980 | 9 669 |
| Equity | — | −170 | −1 024 | −1 447 | 1 923 | 1 870 | 132 | 96 | 158 | 2 079 | 2 604 | 1 158 | 1 369 | 260 | 3 301 | 2 755 | 5 477 | 8 078 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 444 | 1 973 | 2 150 | 0 | 0 | 0 | 3 203 | 3 274 | 1 553 |
| Short-term debt | 0 | 467 | 586 | 133 | 200 | 12 | 62 | 5 | 399 | 194 | 1 111 | 133 | 2 158 | 3 436 | 3 185 | 288 | 229 | 38 |
| Total debt | 0 | 467 | 1 386 | 1 933 | 200 | 12 | 62 | 5 | 399 | 1 638 | 3 084 | 2 283 | 2 158 | 3 436 | 3 185 | 3 491 | 3 502 | 1 591 |
EBITDA margin
98.0%
This company
15.8%
Market median
+520% vs market
20072024
Equity ratio
83.5%
This company
38.2%
Market median
+119% vs market
20072024
Return on equity
32.2%
This company
18.4%
Market median
+75% vs market
20072024
Net profit margin
163.6%
This company
8.1%
Market median
+1920% vs market
20072024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20072024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CAERUS CAPITAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torgeir Vaage | Chairman | 0 companies |